StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.37−0.01 (-3.62%)

Close on Nov 18, 2026Market cap $7.20MP/E –Yield –

Ensysce Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Ensysce Biosciences's profit margin for the twelve months ending Sep 30, 2021 was -663.5%. For fiscal 2020 it was 109.7%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020109.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2021Sep 30, 2021-1429.3%−1619.1
Q2 FY2021Jun 30, 2021-210.5%−171.9
Q1 FY2021Mar 31, 2021-683.1%–
Q4 FY2020Dec 31, 20201072.8%–
Q3 FY2020Sep 30, 2020189.8%–
Q2 FY2020Jun 30, 2020-38.6%–

More Ensysce Biosciences figures

See a number that looks wrong?